Halfway there: The biggest type 1 diabetes prevention trial for babies reaches important milestone
By sara [dot] liedholm [at] med [dot] lu [dot] se (Sara Liedholm) - published 31 January 2020 One of Europe’s largest type 1 diabetes research cooperations has passed a significant milestone: The international platform GPPAD (“The Global Platform for the Prevention of Autoimmune Diabetes”) has successfully included 520 babies across Europe in the type 1 diabetes prevention trial POInT (Primary Ora